Table 1.
Effect | Suggested Mechanism | Relevance to CF | Refs |
---|---|---|---|
Downregulation of epithelial chloride transport | Downregulated CFTR and CaCC expression and function, potentially microRNA mediated | Exacerbates already dysregulated ion transport in epithelia throughout the body in CF | 94, 95, 96 |
Driving goblet cell hyperplasia | Potentially via Smad dependent pathways based upon mouse models of allergen induced airway remodeling | Goblet cell hyperplasia and mucin secretion are pathologic features of CF lung disease | 72, 73, 79 |
Aberrant inflammatory responses | Suppression of innate immune responses with augmented inflammation | CF lungs are known to be primed for a more aggressive inflammatory response, inability to clear chronic infection, and dysregulated innate immunity | 104, 105, 106 |
Enhanced fibrosis | Driving myofibroblast differentiation and aberrant injury response that promotes fibrosis | After cycles of infection and inflammation, fibrotic lung disease significantly contributes to pulmonary decline in CF patients | 56, 100, 101 |
CaCC, Calcium activated Chloride Conductance; CF, cystic fibrosis; CFTR, cystic fibrosis transmembrane conductance regulation.